glp-1 eye GLP-1s Linked to Sudden, Rare Vision Loss GLP-1 drugs may be linked

Moreover, MRP-1 gene silencing results in cellular GSSG accumulation and cell death 33

Here is what has occurred and what patients may expect in the coming months based on manufacturer announcements and regulatory filings: December 22, 2025: FDA approved oral Wegovy (semaglutide 25 mg), the first oral GLP-1 for weight loss

Additionally, these anti-obesity drugs have moved the goalpost for type 2 diabetes and should be considered initial therapy, allowing to attain diabetes reversal or remission which may no longer be the impossible dream to reach, said Rosenstock.

Darkening of pre-existing nevi (moles) and freckles due to increased melanogenesis

Notice: Compliance Statement and Disclaimer